Neurosense Therapeutics Stock Price Transform Average Price

NRSN Stock  USD 0.86  0.07  7.53%   
Neurosense Therapeutics price transform tool provides the execution environment for running the Average Price transformation and other technical functions against Neurosense Therapeutics. Neurosense Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of price transform indicators. As with most other technical indicators, the Average Price transformation function is designed to identify and follow existing trends. Neurosense Therapeutics price transformation methods enable investors to generate trading signals using basic price transformation functions such as typical price movement.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Neurosense Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Neurosense Therapeutics Technical Analysis Modules

Most technical analysis of Neurosense Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurosense from various momentum indicators to cycle indicators. When you analyze Neurosense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Neurosense Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neurosense Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurosense Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Neurosense Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurosense Therapeutics's daily price indicators and compare them against related drivers, such as price transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Neurosense Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Neurosense Therapeutics, we also check how macroeconomic factors affect Neurosense Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2023 2024 (projected)
Current Ratio19.120.840.8
Net Debt To EBITDA3.20.230.22
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neurosense Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.885.47
Details
Intrinsic
Valuation
LowRealHigh
0.122.457.04
Details
Naive
Forecast
LowNextHigh
0.021.005.59
Details
2 Analysts
Consensus
LowTargetHigh
6.607.258.05
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Banking Idea
Banking
Invested over 40 shares
Momentum Idea
Momentum
Invested over 50 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
Impulse Idea
Impulse
Invested few shares
FinTech Idea
FinTech
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
When determining whether Neurosense Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurosense Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurosense Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurosense Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Return On Assets
(1.51)
Return On Equity
(4.95)
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.